<--- Back to Details
First PageDocument Content
Pharmaceutics / Pharmaceutical industry / Anticonvulsants / Mood stabilizers / Dibenzazepines / Bioequivalence / Carbamazepine / Dissolution testing / Abbreviated New Drug Application / Pharmacology / Pharmaceutical sciences / Pharmacokinetics
Pharmaceutics
Pharmaceutical industry
Anticonvulsants
Mood stabilizers
Dibenzazepines
Bioequivalence
Carbamazepine
Dissolution testing
Abbreviated New Drug Application
Pharmacology
Pharmaceutical sciences
Pharmacokinetics

DIVISION OF BIOEQUIVALENCE REVIEW

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 33,25 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvyp - View Document

conferenceseries.com 1575th Conference March 2018 | Volume 7 ISSN: Journal of Pharmaceutics & Drug Delivery Research

DocID: 1vclS - View Document

医療薬学実習(薬剤、大河原賢一), Clinical Pharmacy (Pharmaceutics-2) 項目 A B

DocID: 1uNpr - View Document

ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr

DocID: 1uHNe - View Document

Int. J. Manag. Bus. Res., 6 (1), 23-34, Winter 2016 © IAU Ranking Pharmaceutics Industry Using SD-Heuristics Approach 1*

DocID: 1uqmz - View Document